Ras genes are the most mutated proto-oncogenes in cancer. We propose a new mechanism for oncogenicity in cancer involving a new HRas proto-oncogene. Further studies can be aimed at targeting p14HRas or its mechanisms of expression (also identified here) for a new therapy to treat cancer patients.
|